Cabot CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
CBT
Cabot CORPCabot Corporation reports a substantial decline in Q3 net income and EPS, primarily attributed to increased restructuring expenses and reduced performance in its Reinforcement Materials segment.
NYSE
CBT
Cabot CORPCabot Corporation reported a decline in first-quarter net income and sales, driven by lower volumes and pricing in its Reinforcement Materials segment, despite growth in Performance Chemicals EBIT.
NYSE
CBT
Cabot CORPCabot Corporation reported a decline in third-quarter net income and sales, primarily driven by reduced volumes and less favorable pricing in its Reinforcement Materials segment, despite improved nine-month results due to reduced foreign exchange losses.
NYSE
CBT
Cabot CORPCabot Corporation's Q2 fiscal year 2025 saw a decrease in net sales but an increase in net income, driven by Performance Chemicals' strong performance offsetting lower Reinforcement Materials volumes.
NYSE
CBT
Cabot CORPCabot Corporation's Q1 2025 net income attributable to Cabot Corporation increased to $93 million, up from $50 million in Q1 2024, driven by lower foreign exchange losses and higher segment earnings.
NYSE
CBT
Cabot CORPCabot Corporation's Q3 2024 earnings increased significantly year-over-year, driven by higher volumes in both Reinforcement Materials and Performance Chemicals segments.
NYSE
CBT
Cabot CORPCabot Corporation's Q2 2024 earnings increased due to higher segment profits and investment income, despite a slight decrease in revenue.
NYSE
CBT
Cabot CORPCabot Corporation's first quarter of fiscal year 2024 saw a decrease in net sales but an increase in gross profit, with significant impacts from foreign currency fluctuations.